← Back to guidelines
Dermatology7 papers

Familial dyskinesia and facial myokymia

Last edited: 4/16/2026

Overview

Familial dyskinesia encompasses a range of movement disorders characterized by involuntary muscle contractions, often affecting facial muscles leading to conditions like facial myokymia. These conditions can significantly impact quality of life and may require targeted interventions for symptom management 1.

Diagnosis

  • Clinical evaluation focusing on involuntary movements, particularly in facial muscles.
  • No specific diagnostic tests; diagnosis primarily clinical 1.
  • Grading systems for severity often based on subjective assessment scales (e.g., Burke-Fahn-Marsden Dystonia Rating Scale for related conditions) 1.
  • Management

  • First-line treatments: Botulinum toxin type A injections for focal dystonias and myokymias to reduce muscle hyperactivity 1.
  • Adjunctive treatments: Combination with laser and energy devices may enhance outcomes, though evidence is primarily anecdotal 1.
  • Reassessment and reinjection: Regular follow-ups and reinjections required to maintain therapeutic effects 1.
  • Special Populations

  • Pregnancy: Limited data; caution advised with botulinum toxin use due to potential effects on neuromuscular function 1.
  • Pediatrics: Use of botulinum toxin in pediatric populations requires careful consideration of dosing and safety profiles 1.
  • Elderly: Increased risk of complications such as ptosis and asymmetry; careful injection technique essential 1.
  • Comorbidities: No specific guidance provided; individualized treatment plans recommended considering overall health status 1.
  • Key Recommendations

  • Utilize botulinum toxin type A for symptomatic relief in familial dyskinesia and facial myokymia (Evidence: Moderate 1).
  • Combine injectable treatments with laser and energy devices cautiously, noting limited robust evidence (Evidence: Weak 1).
  • Regular reassessment and reinjection schedules are necessary to sustain therapeutic benefits (Evidence: Expert opinion 1).
  • References

    1 Alam M, Tung R. Injection technique in neurotoxins and fillers: Indications, products, and outcomes. Journal of the American Academy of Dermatology 2018. link

    Original source

    1. [1]
      Injection technique in neurotoxins and fillers: Indications, products, and outcomes.Alam M, Tung R Journal of the American Academy of Dermatology (2018)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG